← Back
$ATHA All transactions

Athira Pharma, Inc.

▼ SELL

$ Value

$11K

Shares

1,644

Price

$7

Filed

Jan 5

Insider

Name

San Martin Javier

Title

CHIEF MEDICAL OFFICER

CIK

0001794629

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,189

Footnotes

The reported number of shares in this Form 4 has been adjusted to reflect the impact of the Issuer's 10-for-1 reverse stock split completed on September 17, 2025 (the "Reverse Stock Split"). | Represents shares of common stock sold to cover tax withholding and remittance obligations in connection with the vesting of restricted stock units ("RSU") pursuant to mandatory "sell to cover" policies maintained by the issuer and provisions contained in the reporting person's applicable RSU agreement, and does not represent a discretionary sale by the reporting person. No additional shares of common stock were sold by the reporting person and the shares of common stock received upon settlement of the RSUs are subject to a lock-up agreement with Cantor Fitzgerald & Co. entered into in connection with the Issuer's private placement in December 2025. | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $6.60 to $7.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. | RSUs convert into common stock on a one-for-one basis. | Each RSU represents a contingent right to receive one (1) share of Issuer's common stock. | On October 1, 2024, the reporting person was granted 14,000 RSUs. One-third (1/3rd) of the RSUs vest on each of December 31, 2024, June 30, 2025 and December 31, 2025, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the applicable vesting dates.

Filing Info

Accession No.

0001794629-26-000002

Form Type

4

Issuer CIK

0001620463

San Martin Javier's History

Date Ticker Type Value
2026-04-09 LONA A $0
2026-03-04 LONA $9K
2026-03-03 LONA M $0
2026-03-03 LONA M $0
2026-01-02 ATHA $11K
2025-12-31 ATHA M $0
2025-12-31 ATHA M $0
2025-12-24 ATHA A $0
2025-07-01 ATHA $3K
2025-06-30 ATHA M $0

Other Insiders at ATHA (90d)

Insider Bought Sold Last
EDELMAN JOSEPH 2026-04-09
FLUKE JOHN M JR 2026-04-09
JOHNSON JAMES A 2026-04-09
PICKERING GRANT 2026-04-09
Litton Mark James
PRESIDENT and CEO
$28K 2026-04-09
Panzara Michael A. 2026-04-09
Romano Kelly A 2026-04-09
Kosacz Barbara 2026-04-09
San Martin Javier
CHIEF MEDICAL OFFICER
$9K 2026-04-09
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
$7K 2026-04-09
Worthington Mark
GENERAL COUNSEL and CCO
$7K 2026-04-09
Renninger Robert
CHIEF FINANCIAL OFFICER
$5K 2026-04-09